United States

Jazz Pharmaceuticals PLC (JAZZ.OQ)

JAZZ.OQ on NASDAQ Stock Exchange Global Select Market

3 May 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for JAZZ.OQ


Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead... (more)


Beta: 0.66
Market Cap(Mil.): $9,216.01
Shares Outstanding(Mil.): 60.44
Dividend: --
Yield (%): --


  JAZZ.OQ Industry Sector
P/E (TTM): 29.17 34.06 44.92
EPS (TTM): 5.23 -- --
ROI: 10.54 13.00 12.47
ROE: 22.19 13.69 13.34
Search Stocks

Jazz Pharmaceuticals' rare liver disorder drug wins U.S. approval

March 30 The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.

Mar 30 2016


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : GlobalData
Provider : ValuEngine, Inc.
Provider : Stock Traders Daily
Provider : Pechala's Reports
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks